Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Dyella thiooxydans strain:ATSB10

Project description:Dyella thiooxydans ATSB10 genome sequencing

| PRJNA309454 | ENA

Pandoraea thiooxydans strain:ATSB16

Project description:Pandoraea thiooxydans ATSB16 genome sequencing

| PRJNA309453 | ENA

Comamonas thiooxydans strain:CHJ01

Project description:Comamonas thiooxydans strain:CHJ01 Genome sequencing

| PRJNA808782 | ENA